Heinrich Dreismann - 09 Jun 2023 Form 4 Insider Report for Talis Biomedical Corp

Role
Director
Signature
/s/ Gillian Green, Attorney-in-fact for Heinrich Dreismann
Issuer symbol
TLIS on OTC
Transactions as of
09 Jun 2023
Net transactions value
$0
Form type
4
Filing time
12 Jun 2023, 17:13:47 UTC
Previous filing
02 Jun 2023
Next filing
07 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLIS Stock option (right to buy) Award $0 +5,466 $0.000000 5,466 09 Jun 2023 Common Stock 5,466 $0.5000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/12th of the shares subject to the option shall vest monthly over one year from the vesting commencement date.